Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Promoting acute thrombolysis for ischemic stroke
ISRCTN ISRCTN20405426
ClinicalTrials.gov identifier
Public title Promoting acute thrombolysis for ischemic stroke
Scientific title
Acronym PRACTISE
Serial number at source 945-14-217
Study hypothesis 1. To evaluate the effect of a high intensity implementation strategy compared to a regular intensity strategy
2. Identify success factors and obstacles for implementation of thrombolysis
3. To assess the cost-effectiveness of thrombolysis in routine daily Dutch neurological care settings, taking into account the costs of implementation
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Netherlands
Disease/condition/study domain Stroke
Participants - inclusion criteria All patients who are admitted with acute stroke i.e. patients with an acute focal neurological deficit, which cannot be explained by a condition other than stroke, and onset of symptoms not longer than 24 hours ago
Participants - exclusion criteria Age under 18
Anticipated start date 01/08/2005
Anticipated end date 01/08/2007
Status of trial Completed
Patient information material
Target number of participants 7,000
Interventions The high intensity intervention consists of the introduction of a set of implementation tools, directed at the four levels where barriers are expected. This toolkit will be explained in a training session to the vascular neurologist and coordinating nurse in each center, who also act as the local agents of change. Training session takes place after 6 months and 1 year.

Control: regular intensity strategy
Primary outcome measure(s) Treatment with thrombolysis or not in all registered patients
Secondary outcome measure(s) Admission within 3 hours after onset of symptoms, death or disability at three months (in the subgroup of patients with ischemic stroke who were admitted within 3 hours).
Sources of funding Netherlands Organisation for Health Research and Development (ZonMw) (945-14-217)
Trial website http://www.practise-trial.org
Publications 2007 protocol in http://www.ncbi.nlm.nih.gov/pubmed/18705977
Contact name Dr  Diederik W.J.  Dippel
  Address PO Box 1738
  City/town Rotterdam
  Zip/Postcode 3000 DR
  Country Netherlands
  Tel +31 (0)10 4087979
  Fax +31 (0)10 4089446
  Email d.dippel@erasmusmc.nl
Sponsor Netherlands Organisation for Health Research and Development (ZonMw)
  Address Laan van Nieuw Oost Indië 334
P.O. Box 93245
  City/town The Hague
  Zip/Postcode 2509 AE
  Country Netherlands
  Tel +31 (0)70 349 5111
  Fax +31 (0)70 349 5100
  Email info@zonmw.nl
  Sponsor website: http://www.zonmw.nl
Date applied 24/06/2005
Last edited 11/09/2009
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central